88 related articles for article (PubMed ID: 28019011)
1. Prognostic value of biochemical variables for survival after surgery for metastatic bone disease of the extremities.
Sørensen MS; Hovgaard TB; Hindsø K; Petersen MM
J Surg Oncol; 2017 Mar; 115(4):442-448. PubMed ID: 28019011
[TBL] [Abstract][Full Text] [Related]
2. Incidence of surgical interventions for metastatic bone disease in the extremities: a population-based cohort study.
Skovlund Sørensen M; Hindsø K; Frederik Horstmann P; Troelsen A; Dalsgaard S; Fog T; Zimnicki T; Mørk Petersen M
Acta Oncol; 2019 Apr; 58(4):456-462. PubMed ID: 30632859
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
[TBL] [Abstract][Full Text] [Related]
5. Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer.
Huang P; Lan M; Peng AF; Yu QF; Chen WZ; Liu ZL; Liu JM; Huang SH
PLoS One; 2017; 12(9):e0183835. PubMed ID: 28902911
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer.
Sonpavde G; Pond GR; Armstrong AJ; Clarke SJ; Vardy JL; Templeton AJ; Wang SL; Paolini J; Chen I; Chow-Maneval E; Lechuga M; Smith MR; Michaelson MD
Clin Genitourin Cancer; 2014 Oct; 12(5):317-24. PubMed ID: 24806399
[TBL] [Abstract][Full Text] [Related]
7. 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?
Janssen SJ; van der Heijden AS; van Dijke M; Ready JE; Raskin KA; Ferrone ML; Hornicek FJ; Schwab JH
Clin Orthop Relat Res; 2015 Oct; 473(10):3112-21. PubMed ID: 26155769
[TBL] [Abstract][Full Text] [Related]
8. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.
Proctor MJ; McMillan DC; Horgan PG; Fletcher CD; Talwar D; Morrison DS
PLoS One; 2015; 10(3):e0116206. PubMed ID: 25730322
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.
Proctor MJ; Horgan PG; Talwar D; Fletcher CD; Morrison DS; McMillan DC
Cancer; 2013 Jun; 119(12):2325-32. PubMed ID: 23575969
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction.
Sawant AC; Adhikari P; Narra SR; Srivatsa SS; Mills PK; Srivatsa SS
Cardiol J; 2014; 21(5):500-8. PubMed ID: 24142685
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.
Errani C; Cosentino M; Ciani G; Ferra L; Alfaro PA; Bordini B; Donati DM
Int Orthop; 2021 May; 45(5):1337-1346. PubMed ID: 33392682
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma.
de Martino M; Pantuck AJ; Hofbauer S; Waldert M; Shariat SF; Belldegrun AS; Klatte T
J Urol; 2013 Dec; 190(6):1999-2004. PubMed ID: 23831313
[TBL] [Abstract][Full Text] [Related]
16. Metastatic bone disease of the pelvis and extremities: rationalizing orthopaedic treatment.
Kirkinis MN; Spelman T; May D; Choong PFM
ANZ J Surg; 2017 Nov; 87(11):940-944. PubMed ID: 27091575
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
18. [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].
Kiliç T; Ural E; Oner G; Sahin T; Kiliç M; Yavuz S; Kanko M; Kahraman G; Bildirici U; Berki KT; Ural D
Anadolu Kardiyol Derg; 2009 Aug; 9(4):280-9. PubMed ID: 19666429
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.
Teramukai S; Kitano T; Kishida Y; Kawahara M; Kubota K; Komuta K; Minato K; Mio T; Fujita Y; Yonei T; Nakano K; Tsuboi M; Shibata K; Furuse K; Fukushima M
Eur J Cancer; 2009 Jul; 45(11):1950-8. PubMed ID: 19231158
[TBL] [Abstract][Full Text] [Related]
20. Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty.
Ghanem E; Parvizi J; Burnett RS; Sharkey PF; Keshavarzi N; Aggarwal A; Barrack RL
J Bone Joint Surg Am; 2008 Aug; 90(8):1637-43. PubMed ID: 18676892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
